Global Harmonization of Pediatric Drug Development: Critical for Progress for Developing Safe and Effective Therapeutic Agents for Children

The article, "Questionable Industry-Sponsored Studies in Children and Adolescents in Slovenia" provides an opportunity to discuss evolving US and EU legislative measures to improve the available clinical trial-derived pediatric data and provide coherent labeling for pediatric providers in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulberg, Andrew E., Cripps, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677566/
https://www.ncbi.nlm.nih.gov/pubmed/31388364
http://dx.doi.org/10.1016/j.curtheres.2019.01.006
_version_ 1783440923398504448
author Mulberg, Andrew E.
Cripps, Timothy
author_facet Mulberg, Andrew E.
Cripps, Timothy
author_sort Mulberg, Andrew E.
collection PubMed
description The article, "Questionable Industry-Sponsored Studies in Children and Adolescents in Slovenia" provides an opportunity to discuss evolving US and EU legislative measures to improve the available clinical trial-derived pediatric data and provide coherent labeling for pediatric providers in dosing of drugs for children.
format Online
Article
Text
id pubmed-6677566
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-66775662019-08-06 Global Harmonization of Pediatric Drug Development: Critical for Progress for Developing Safe and Effective Therapeutic Agents for Children Mulberg, Andrew E. Cripps, Timothy Curr Ther Res Clin Exp Review Article The article, "Questionable Industry-Sponsored Studies in Children and Adolescents in Slovenia" provides an opportunity to discuss evolving US and EU legislative measures to improve the available clinical trial-derived pediatric data and provide coherent labeling for pediatric providers in dosing of drugs for children. Elsevier 2019-01-26 /pmc/articles/PMC6677566/ /pubmed/31388364 http://dx.doi.org/10.1016/j.curtheres.2019.01.006 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Mulberg, Andrew E.
Cripps, Timothy
Global Harmonization of Pediatric Drug Development: Critical for Progress for Developing Safe and Effective Therapeutic Agents for Children
title Global Harmonization of Pediatric Drug Development: Critical for Progress for Developing Safe and Effective Therapeutic Agents for Children
title_full Global Harmonization of Pediatric Drug Development: Critical for Progress for Developing Safe and Effective Therapeutic Agents for Children
title_fullStr Global Harmonization of Pediatric Drug Development: Critical for Progress for Developing Safe and Effective Therapeutic Agents for Children
title_full_unstemmed Global Harmonization of Pediatric Drug Development: Critical for Progress for Developing Safe and Effective Therapeutic Agents for Children
title_short Global Harmonization of Pediatric Drug Development: Critical for Progress for Developing Safe and Effective Therapeutic Agents for Children
title_sort global harmonization of pediatric drug development: critical for progress for developing safe and effective therapeutic agents for children
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677566/
https://www.ncbi.nlm.nih.gov/pubmed/31388364
http://dx.doi.org/10.1016/j.curtheres.2019.01.006
work_keys_str_mv AT mulbergandrewe globalharmonizationofpediatricdrugdevelopmentcriticalforprogressfordevelopingsafeandeffectivetherapeuticagentsforchildren
AT crippstimothy globalharmonizationofpediatricdrugdevelopmentcriticalforprogressfordevelopingsafeandeffectivetherapeuticagentsforchildren

Ejemplares similares